Antonella Ciancetta

Dr. Antonella Ciancetta

Department of Chemical, Pharmaceutical and Agricultural Sciences; University of Ferrara, 44121 Ferrara, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAna Paula Martins
Ana Paula Martins
AMAlessandro Marrone
Alessandro Marrone
Antonella CiancettaAntonella Ciancetta
Antonella Ciancetta
ACAna Galan Cobo
Ana Galan Cobo
Miriam EchevarríaMiriam Echevarría
Miriam Echevarría
Graça SoveralGraça Soveral
Graça Soveral
Aquaporins (AQPs) are membrane channels that conduct water and small solutes such as glycerol and are involved in many physiological functions. Aquaporin-based modulator drugs are predicted to be of broad potential utility in the treatment of several diseases. Until today few AQP inhibitors have been described as suitable candidates for clinical development. Here we report on the potent inhibition of AQP3 channels by gold(III) complexes screened on human red blood cells (hRBC) and AQP3-transfected PC12 cells by a stopped-flow method. Among the various metal compounds tested, Auphen is the most active on AQP3 (IC50 = 0.8±0.08 µM in hRBC). Interestingly, the compound poorly affects the water permeability of AQP1. The mechanism of gold inhibition is related to the ability of Au(III) to interact with sulphydryls groups of proteins such as the thiolates of cysteine residues. Additional DFT and modeling studies on possible gold compound/AQP adducts provide a tentative description of the system at a molecular level. The mapping of the periplasmic surface of an homology model of human AQP3 evidenced the thiol group of Cys40 as a likely candidate for binding to gold(III) complexes. Moreover, the investigation of non-covalent binding of Au complexes by docking approaches revealed their preferential binding to AQP3 with respect to AQP1. The high selectivity and low concentration dependent inhibitory effect of Auphen (in the nanomolar range) together with its high water solubility makes the compound a suitable drug lead for future in vivo studies. These results may present novel metal-based scaffolds for AQP drug development.

14 April 2016 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
ACAlberto Cuzzolin
Alberto Cuzzolin
Mattia SturleseMattia Sturlese
Mattia Sturlese
GDGiuseppe Deganutti
Giuseppe Deganutti
Veronica SalmasoVeronica Salmaso
Veronica Salmaso
DSDavide Sabbadin
Davide Sabbadin
Stefano MoroStefano Moro
Stefano Moro

14 May 2010 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
ACAngela Casini
Angela Casini
FEFabio Edafe
Fabio Edafe
MEMikael Erlandsson
Mikael Erlandsson
Luca GonsalviLuca Gonsalvi
Luca Gonsalvi
Antonella CiancettaAntonella Ciancetta
Antonella Ciancetta
PDPaul Dyson
Paul Dyson
A series of organometallic compounds of general formula [(arene)M(PTA)nXm]Y (arene = η6-C10H14, η-C5Me5); M = Ru(II), Os(II), Rh(III) and Ir(III); X = Cl, mPTA; Y = OTf, PF6) have been screened for their cytotoxicity and ability to inhibit cathepsin B in vitro, in comparison to the antimetastatic compound NAMI-A. The Ru and Os analogues and NAMI-A showed similar enzyme inhibition properties (with IC50 values in the low μM range), whereas the Rh(III) and Ir(III) compounds were inactive. In order to build up a rational for the observed differences, DFT calculations of the metal complexes adducts with N-acetyl-L-cysteine-N′-methylamide, a mimic for the Cys residue in the cathepsin B active site, were performed to provide insights into binding thermodynamics in solution. Initial structure–activity relationships have been defined with the calculated binding energies of the M–S bonds correlating well with the observed inhibition properties of the compounds.

7 May 2013 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
AMAna Paula Martins
Ana Paula Martins
Antonella CiancettaAntonella Ciancetta
Antonella Ciancetta
AAAndreia De Almeida
Andreia De Almeida
AMAlessandro Marrone
Alessandro Marrone
NRNazzareno Re
Nazzareno Re
ACAngela Casini
Angela Casini


1 December 2015 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
Antonella CiancettaAntonella Ciancetta
Antonella Ciancetta
DSDavide Sabbadin
Davide Sabbadin
Stephanie FedericoStephanie Federico
Stephanie Federico
GSGiampiero Spalluto
Giampiero Spalluto
Stefano MoroStefano Moro
Stefano Moro